Gregg C. Johnson
Director · Vivos Therapeutics, Inc.
Individual
- 2024
- Sep 19, 2026
- 4
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Gregg C. Johnson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael C. Skaff - $10.37M in VVOS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Gregg C. Johnson?
Gregg C. Johnson is a corporate insider, tracked as Director of Vivos Therapeutics, Inc. (VVOS). InsiderAlpha holds 4 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Gregg C. Johnson submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
